ALMKT:EPA
Mauna Kea Technologies SA
0,091 €
arrow_downward
−1,62%(−0,0015) 1 p
6. nov, 17:35:04 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
18,26 mln
Keskm. maht
549,48 tuh
Maht
385,57 tuh
Hinna ja tulu suhe
0,78
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
18,26 mln
Keskm. maht
549,48 tuh
Maht
385,57 tuh
Hinna ja tulu suhe
0,78
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
Finviz
·
1 tunni eest
PSQ Holdings Shrinks Losses And Cash Burn, But Slowing Growth, A Steep Q4 Target And NYSE Listing Risk Define The Setup
Yahoo Finance
·
42 minuti eest
After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.
Central Oregon Daily
·
32 minuti eest
Nasdaq rebounds but remains on track for fourth straight weekly decline
Seeking Alpha
·
39 minuti eest
Top 20 S&P 500 Ranked By PEG Ratio After Massive Tech Route (NYSEARCA:SPY)
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com